Human immunodeficiency virus infection in tuberculosis patients

J Infect Dis. 1990 Jul;162(1):8-12. doi: 10.1093/infdis/162.1.8.

Abstract

Human immunodeficiency virus (HIV) serology was performed in non-Asian-born patients 18-65 years old with newly diagnosed tuberculosis at a county tuberculosis clinic, and demographic and clinical features of HIV-seropositive and HIV-seronegative patients were compared. Sixty of 128 eligible patients agreed to participate, of whom 17 (28%) were seropositive. Risk of HIV was associated with homosexual contact, intravenous drug use, or both; however, 4 (24%) of the 17 seropositives denied risk behaviors. Significantly more blacks (48%) than whites (10%) or Latinos (20%) were HIV-seropositive (P less than .01). Site of disease, tuberculin reactivity, response to therapy, drug toxicity, and relapse did not differ significantly between groups. HIV-seropositive patients had significantly lower median CD4+ cell counts (326/mm3, range 23-742/mm3, vs. 929/mm3, range 145-2962/mm3, P less than .0005) and median CD4+:CD8+ ratios (0.50, range 0.14-1.07 vs. 1.54, range 0.35-4.36, P less than .0001). HIV infection is associated with clinically typical tuberculosis and HIV screening of tuberculosis patients is recommended in areas where HIV is endemic.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Adult
  • Age Factors
  • Antitubercular Agents / therapeutic use
  • CD4-Positive T-Lymphocytes
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology
  • HIV Seropositivity / complications
  • HIV Seroprevalence
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Opportunistic Infections / complications*
  • Risk Factors
  • Sex Factors
  • Sputum / microbiology
  • Tuberculin Test
  • Tuberculosis / complications*
  • Tuberculosis / drug therapy

Substances

  • Antitubercular Agents